Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Cantor Fitzgerald Starts Accenture plc (ACN) at Buy
-
Cantor Fitzgerald Starts Virtusa (VRTU) at Buy
-
Profile Technologies (PRTK) Enters $50M Controlled Equity Offering Agreement
-
FallLine Securities LLC Names Michael R. Gault Partner and Head of Client Services
-
Signal Hill Hires Senior Banker, Grows Capabilities in Private Placements
-
TPG Specialty Lending, Inc. Questions Payment to Failed Leadership in Letter to TICC Capital Corp. Stockholders
-
Notable Analyst Rating Changes 10/9: (ALB) (MT) (RPD) Upgraded; (FEYE) (TSLA) (PCAR) Downgraded
-
Sturdy quarter likely for financials, but ETF investors cautious
-
Cantor Fitzgerald Starts Ocata (OCAT) at Buy
-
Orchid Island Capital Announces October 2015 Monthly Dividend and September 30, 2015 RMBS Portfolio Characteristics
-
Cantor Fitzgerald Starts Barnes & Noble Education (BNED) at Hold
-
Cantor Fitzgerald Starts Gannett (GCI) at Buy
-
Cantor Fitzgerald Starts Madison Square Garden (MSG) at Buy
-
Cantor Fitzgerald Starts MSG Networks (MSGN) at Hold
-
Cantor Fitzgerald Starts KLX Inc (KLXI) at Buy
-
Cantor Fitzgerald Starts Barnes & Noble (BKS) at Buy
-
PlacementTracker Publishes Third Quarter 2015 PIPE Market League Tables
-
Mirna Therapeutics Announces Closing of Initial Public Offering and Concurrent Private Placement with CPRIT
-
Reminder - Capital Link's 2nd Annual Dissect ETFs Forum
-
Cantor Fitzgerald Reiterates Buy on Applied Genetic Technologies (AGTC) Following Recent Positive Gene Therapy News
-
'Jack Back' an Incremental Positive for Twitter (TWTR), Cantor Fitzgerald Says
-
TPG Specialty Lending, Inc. Files Definitive Proxy Materials with SEC to Solicit TICC Capital Corp. Stockholders to Vote AGAINST the Inferior Benefit Street Partners Transaction
-
Drexel Hamilton Starts Apple (AAPL) at Buy; $200 PT
-
Drexel Hamilton Hires Brian J. White as Senior Equity Research Analyst, Broadens Tech/Media/Telecom Coverage
-
Mirna Therapeutics (MIRN) IPO Opens Modestly Higher
-
Cantor Fitzgerald Reiterates Buy on Alimera Sciences (ALIM) Following Investor Meetings
-
Mirna Therapeutics (MIRN) Prices 6.25M Common Stock IPO at $7/Share
-
Mirna Therapeutics Announces Pricing of Its Initial Public Offering
-
Energy Fuels (UUUU) Begins Construction at Nichols Ranch; Offers Other Operational Updates
-
Energy Fuels Announces Augmentation of Uranium Production Capabilities at Nichols Ranch, Establishment of Normal Course Issuer Bid on Convertible Debentures, and Filing of Prospectus Supplement
-
Energy XXI Reports Fiscal Year-End Results
-
Energy XXI Reports Fiscal Year-End Results
-
The Siegfried Group Welcomes New Professionals from the Central Region for New Hire Orientation
-
Cantor Fitzgerald Reiterates Buy on Array Biopharma (ARRY) Following Reported ECC/ESMO Data
-
Cantor Fitzgerald Downgrades Verastem (VSTM) to Hold
-
TPG Specialty Lending, Inc. Demonstrates Superior Value of Its Proposal in Letter to TICC Capital Corp. Stockholders
-
Cantor Fitzgerald Reiterates Buy on Shutterstock (SSTK) Following Intra-Quarter Checks
-
Cantor Fitzgerald Reiterates Buy on Radius Health (RDUS) Following Phase I Safety Results
-
GFI Group Amends Terms of Previously Announced Consent Solicitation
-
2015 Emmy Awards Seen as Disappointment for Netflix (NFLX)
-
TPG Specialty Lending, Inc. Sends Letter to TICC Capital Corp. Stockholders Outlining Merits of Proposal
-
Cantor Fitzgerald Cuts Price Target on Immunogen (IMGN) Following Program Adjustments
-
Dividend payers get a break from Fed decision
-
Notable Analyst Rating Changes 9/18: (PPL) (AET) (SAN) Upgraded; (SPN) (IRBT) (HP) Downgraded
-
Cantor Fitzgerald Upgrades Aetna (AET) to Buy
-
Cantor Fitzgerald Upgrades Essex Property Trust (ESS) to Buy
-
Aerie Pharma (AERI) PT Raised to $40 at Cantor Fitzgerald
-
Cantor Fitzgerald Raises Price Target on Expedia (EXPE) Following DOJ's Approval of Orbitz Acquisition
-
Farmland Partners Inc. Announces Commencement of $25 Million At-the-Market Equity Offering Program
-
Capital Link's 2nd Annual Dissect ETFS Forum

